NCBI Gene symbol: MIR17HG
lncRNA name in article Virus & Strain Name Dosage & Time point Cell line Experiment Type Fold change Expression P-value Differential expression quantification method Statistical method Year PubMed ID
MIR17HG Enterovirus 71 (GDFS-3 strain of EV 71) 10^2 TCID50/mL ;
24 hr
RD Human embryonal rhabdomyosarcoma cells RNA-Seq 2.997594 Upregulation p < 0.05 GeneSpring GX v12.0 software package (Agilent Technologies) Not provided 2013 23220233
MIR17HG Enterovirus 71 (GDFS-3 strain of EV 71) 10^2 TCID50/mL ;
24 hr
RD Human embryonal rhabdomyosarcoma cells RNA-Seq 2.5827105 Upregulation p < 0.05 GeneSpring GX v12.0 software package (Agilent Technologies) Not provided 2013 23220233
MIR17HG Coxsackie virus B3 (CG strain of CVB3) MOI = 0.5 ;
23 hr
HeLa Human papillomavirus-related endocervical adenocarcinoma cells Microarray 2.3589103 Upregulation 0.000141 GeneSpring GX v11.5.1 software package (Agilent Technologies) student's t test  2019 31388922
MIR17HG Coxsackie virus B3 (CG strain of CVB3) MOI = 0.5 ;
23 hr
HeLa Human papillomavirus-related endocervical adenocarcinoma cells Microarray 2.4094963 Upregulation 0.000141 GeneSpring GX v11.5.1 software package (Agilent Technologies) student's t test  2019 31388922
MIR17HG Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 2 ;
24 hr
A-549 Human adenocarcinomic alveolar basal epithelial cells RNA-Seq 1.584667323 Upregulation 0.00693376 student's t test  2020 32416070
MIR17HG Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 2 ;
24 hr
Calu-3 Human adenocarcinomic lung epithelialcells RNA-Seq 2.027806511 Upregulation 0.026181121 student's t test  2020 32416070

* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose

.